Liu and colleagues have demonstrated a tumor-grade dependent increase in HK2 protein expression (Liu et al., 2017), whereas Mukherjee and colleagues have demonstrated a tumor-grade dependent increase in PKM2 gene expression (Mukherjee et al., 2013). The gene discussed is HK2; the disease is neoplasm.